Althea Medical

Company Overview

Snapshot

Founded in November 2020 by Lia Ofek and Rafi Benary, Althea Medical operates with 1–10 employees. The company has raised $1.6M across 5 funding rounds from 3 investors. In January 2024, Peregrine Ventures participated in a funding round.

Business overview

Althea Medical is a medical device startup specializing in developing a catheter-based solution for treating patients with massive and sub-massive pulmonary embolism. The company's core technology is an over-the-wire novel system designed for mechanical clot removal, combining the efficiency of large-bore thrombectomy with an easy-to-use delivery method to minimize patient risks. Althea Medical operates within the Health Tech & Life Sciences sector, specifically targeting the medical devices industry and healthcare providers with its innovative medical treatment and therapeutics.

Strategic signal

In August 2023, Althea Medical was highlighted for its efforts to prevent pulmonary embolism, a leading cause of preventable hospital deaths. This signals the company's focus on addressing critical unmet medical needs and its potential to significantly impact patient outcomes and healthcare efficiency, attracting attention from investors and innovation teams seeking solutions in high-impact medical device areas.

Company Intelligence Q&A

What is Althea Medical's primary focus?

Althea Medical develops a minimally invasive catheter-based solution for treating patients suffering from massive and sub-massive pulmonary embolism.

When was Althea Medical founded?

Althea Medical was founded in November 2020.

Which investors participated in Althea Medical's January 2024 funding round?

In January 2024, Peregrine Ventures participated in a funding round for Althea Medical.

What is the total capital raised by Althea Medical?

Althea Medical has raised a total of $1.6M across its funding rounds.

What is the status of Althea Medical?

Althea Medical is currently non-active, having ceased to operate in November 2025.